Drug Target Review – Issue 1 2020

Posted: 23 March 2020 | | No comments yet

This issue includes a spotlight on how genomic assays could revolutionise healthcare, a discussion on how lab automation can improve drug discovery and an analysis of whether antibodies can provide an effective coronavirus treatment. Other article topics in this issue include immuno-oncology and artificial intelligence.

Drug Target Review Issue 1 Front Cover

Included in this issue:

    In vitro platforms for de-risking nephrotoxicity during drug development
    Colin Brown, Newcells Biotech
    Sandy Primrose, Newcells Biotech
    Scientific data management: the core of quality
    Roberto Castelnovo, NL42 Consulting
    Not everyone loves surprises: know your ADC’s critical quality attributes
    Omar Lamm, MilliporeSigma
    Martin De Cecco, Merck
    Cell line development for therapeutic proteins – current perspectives and future opportunities
    Dr Jonathan H Dempsey, Dempsey Consulting
    How labs become AI ready with advanced informatics infrastructures
    Unjulie Bhanot, IDBS

The rest of this content is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here